Dissemination of results
Publications
The Institute is a powerhouse of scientific excellence and innovation. We publish in top level journals including: New England Journal of Medicine, Nature, Nature Biotechnology, Nature Medicine, Cell, J. Exp. Med., The Lancet, The Lancet Infectious Disease, Nature Commun, and specialty journals including J. Hepatol., Hepatology, Gut, Gastroenterology, and JCI Insight.
Highlighted papers
An atlas of the human liver diurnal transcriptome and its perturbation by hepatitis C virus infection
Mukherji, A., et al. (2024)
Targeting the liver clock improves fibrosis by restoring TGF-β signaling
Crouchet, E., et al. (2024)
JAK1 promotes HDV replication and is a potential target for antiviral therapy
Heuschkel, M., et al. (2024)
A stable hepatitis D virus-producing cell line for host target and drug discovery
Bach, C., et al. (2023)
A human liver cell-based system modeling a clinical prognostic liver signature for therapeutic discovery
Crouchet, E., et al. (2021)
A genome-wide gain-of-function screen identi8es CDKN2C as a HBV host factor
Eller, C., et al. (2020)
A human liver cell atlas reveals heterogeneity and epithelial progenitors
Aizarani, N., et al. (2019)
RACK1 controls IRES-mediated translation of viruses
Majzoub, K., et al. (2014)
Curing Chronic Hepatitis C — The Arc of a Medical Triumph
Chung, R.T., et al. (2014)
Publication record
Other Dissemination
Our team members are regularly attending conferences and scientific events, where they are invited to present their work as posters or oral communications.